Note: In this book, 15 cancer doctors share the details of their treatment protocols and answer difficult questions about cancer. Each physician is given their own chapter. The page you are viewing contains sample material; to read the rest of the book, you can place your order for the book from the publisher, Amazon, or Barnes & Noble. You can also buy the Kindle Edition.

EXCERPTED FROM Dr. Burzynski’s Chapter: Many of our patients with most types of cancer have experienced positive results whenever we give them the right combination of gene-targeted medications. We keep a long list of the various cancers our patients have had and the response rate that we have achieved with each of them. Overall, we have an up to 60 percent response rate for many types of advanced cancers, meaning the patient’s tumors have disappeared or substantially decreased. This response rate applies for all common types of cancer: breast, prostate, liver, colon, lung, and others. Some cancers have a higher response rate than others, but overall, our success rate is anywhere from 40-60 percent. These statistics represent, in their majority, people who were initially given a terminal diagnosis and who came to us after conventional treatments failed them.  For certain types of brain tumors, we have an over 60 percent partial or complete response rate. For malignant melanoma, we have an objective response rate of around 40 percent. In breast cancer, approximately 60 percent of our patients have an objective response rate. (“Objective” here means that patients’ response to the treatment was complete, partial, mixed, or improved.) These terms are defined in greater detail on the “Comparison of Responses in (the) Most Common Cancers” chart at the end of this chapter. Perhaps one-third of our patients who have other types of cancer have a complete remission of their tumors.

In general, we have many long-term survivors because we have been using antineoplastons for a long time and we have been able to track our patients over the years. Again, these are all people who once had incurable cancers and the worst types of malignancies, which historically, nobody has been able to cure. But, we have been able to cure many of them, and what I mean by cure is that they have been tumor-free, for five, ten, even twenty years. They lead normal lives and nobody can tell that they ever had a cancer that was supposed to kill them within a few months.

My work represents the first time in medical history that a treatment has been able to consistently cure untreatable, inoperable tumors. Take for instance, inoperative, malignant gliomas, which are located in the brainstem. Normally, patients with this cancer are given three months to live, but we have one patient who had this malignancy and who is still alive, twenty-three years later, and who remains in perfect health. Such people took antineoplastons for a normal period of time; say, a year, or a year and a half, before they got healed and forgot about their cancers. They are now graduating from college, having families, working, and leading happy, normal lives.

I have been practicing medicine for 44 years, and I have been doing antineoplaston treatment for 34 years. We have patients who have followed up with us 27 years after having received treatment from us, and who are still doing well today. To have this kind of thing happen isn’t unusual for us.

[End Excerpt]

Buy the book to read the rest of this chapter. The following are additional sections contained in this chapter:

  • What Cancer Is, What Causes It, and How to Treat It
  • Antineoplastons for Controlling Cancer Cells
  • How I Discovered Antineoplastons
  • Using Antineoplastons and Gene-Targeted Therapy to Treat Cancer
  • Treatment Process
  • Types of Antineoplastic and Gene-Targeted Medications
  • Use of Antineoplastons for Other Diseases
  • Dietary and Supplement Recommendations
  • Preventing Cancer with Supplements
  • Detoxification
  • Treatment Outcomes
  • Training Other Doctors to Use Antineoplastons
  • Improving Cancer Care
  • The Problem with Conventional Oncology
  • When to Use Conventional Medicine to Treat Cancer
  • Side Effects of Gene-Targeted Therapies
  • Other Factors That Affect Patients’ Healing
  • How Family and Friends Can Support Their Loved Ones with Cancer
  • Roadblocks to Healing
  • Insurance Coverage for Treatments
  • The Politics of Cancer Treatment in the United States and My Battle with the FDA
  • The Future of Cancer Treatment
  • Last Words
  • Useful Websites
  • Last Words

Buy the book to finish reading this chapter.

444 Pages, $39.95